26 February 2024 Foley Ignite
The Corporate Transparency Act and the Impact on M&A in the U.S.
2024 ushered in a seismic shift for mergers and acquisitions in the U.S. with the implementation of the Corporate Transparency Act.
26 February 2024 Article
New SEC Marketing Rule FAQ: IRR Calculations When Using Subscription Lines
On February 6, 2024, SEC staff issued FAQ guidance with respect to registered investment advisers’ obligations under Rule 206(4)-1 of the Investment Advisers Act of 1940.
26 February 2024 Health Care Law Today
OIG Opines on Subsidizing Medicare Cost-Sharing for Clinical Trials
In a recent Advisory Opinion No. 23-11, the Office of Inspector General opined that it will not impose administrative sanctions against a clinical trial sponsor covering up to $2,000 of a clinical trial participant’s cost-sharing obligations